Neuberger Berman Group
DERM icon

Neuberger Berman Group’s Journey Medical DERM Stock Holding History

Neuberger Berman Group’s Portfolio DERM Stock Details DERM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$75.2K Buy
16,036
+85
+0.5% +$660 ﹤0.01% 2097
2025
Q4 		$123K Sell
15,951
-3,781
-19% -$29.6K ﹤0.01% 2003
2025
Q3 		$140K Sell
19,732
-2,243
-10% -$16.3K ﹤0.01% 1947
2025
Q2 		$158K Sell
21,975
-750
-3% -$5.18K ﹤0.01% 1929
2025
Q1 		$134K Sell
22,725
-5,770
-20% -$28.4K ﹤0.01% 1854
2024
Q4 		$111K Sell
28,495
-35,899
-56% -$196K ﹤0.01% 1851
2024
Q3 		$364K Sell
64,394
-3,900
-6% -$20.1K ﹤0.01% 1614
2024
Q2 		$385K Sell
68,294
-13,100
-16% -$53.9K ﹤0.01% 1574
2024
Q1 		$300K Sell
81,394
-13,085
-14% -$56.9K ﹤0.01% 1645
2023
Q4 		$544K Sell
94,479
-16,075
-15% -$71.6K ﹤0.01% 1460
2023
Q3 		$303K Sell
110,554
-9,300
-8% -$20.8K ﹤0.01% 1599
2023
Q2 		$191K Sell
119,854
-8,975
-7% -$14.4K ﹤0.01% 1711
2023
Q1 		$202K Sell
128,829
-3,592
-3% -$6.7K ﹤0.01% 1716
2022
Q4 		$254K Sell
132,421
-29,286
-18% -$57.9K ﹤0.01% 1644
2022
Q3 		$398K Sell
161,707
-35,430
-18% -$121K ﹤0.01% 1530
2022
Q2 		$737K Sell
197,137
-500
-0.3% -$1.98K ﹤0.01% 1378
2022
Q1 		$955K Sell
197,637
-1,475
-0.7% -$7.36K ﹤0.01% 1356
2021
Q4 		$1.07M Buy
+199,112
New +$1.44M ﹤0.01% 1344

Other funds holding DERM

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
PFCS
Pale Fire Capital SE Prague, Czech Republic $1.14B AUM 42.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Neuberger Berman Group's DERM Position: Q1 2026 in Review

Neuberger Berman Group increased its Journey Medical (DERM) stake by 0.53% in Q1 2026, buying an estimated $660 and bringing the position to 16,036 shares worth $75.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2097.

Neuberger Berman Group first reported a position in DERM in Q4 2021 and has held it in 18 quarters since. The position peaked at $1.07M in Q4 2021. 71 funds tracked by Wall St. Rank hold DERM as of Q1 2026.

  • Neuberger Berman Group held 16,036 shares of Journey Medical worth $75.2K as of Q1 2026.
  • Neuberger Berman Group bought 85 Journey Medical shares in Q1 2026, an estimated $660.
  • Journey Medical made up ﹤0.01% of Neuberger Berman Group's portfolio in Q1 2026, its #2097 holding.
  • Neuberger Berman Group first reported a position in Journey Medical in Q4 2021 and has held it in 18 quarters since.
  • Neuberger Berman Group's Journey Medical position peaked at $1.07M in Q4 2021.
  • 71 funds tracked by Wall St. Rank held Journey Medical as of Q1 2026.

Based on Neuberger Berman Group's 13F filing for Q1 2026, filed 14 May 2026.